Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Tetracycline and Nicotinamide for the Treatment of Bullous Pemphigold: Our Experience in Singapore

< Back to Listing

Share this Article

Singapore Med J 2000; 41(7): 327-330
Tetracycline and Nicotinamide for the Treatment of Bullous Pemphigold: Our Experience in Singapore

  • Abstract
  • PDF

ATJ Goon, SH Tan, LSW Khoo, T Tan
Correspondence: Dr Anthony Goon Teik Jin

ABSTRACT
Aim of Study
 To study the efficacy of tetracycline (or doxycycline) and nicotinamide in the treatment of less extensive bullous pemphigoid.
Methods An open trial of 11 patients with bullous pemphigoid. Treatment was initiated with tetracycline 1.5-2 g/day and nicotinamide 1.5-2 g/day and gradually tapered down. Doxycycline was substituted for tetracycline in patients who could not tolerate tetracycline due to gastrointestinal side effects or headache.
Results 6 out of 11 patients achieved complete response (> 90% decrease in lesions) while another 2 had partial response (50-90% decrease in lesions).
Conclusion Tetracycline/doxycycline and nicotinamide is a useful alternative treatment for localized bullous pemphigoid, especially in those whose concurrent medical illnesses preclude the use of systemic corticosteroids.

Keywords: Bullous pemphigoid, tetracycline, nicotinamide
Singapore Med J 2000; 41(7): 327-330

http://smj.org.sg/sites/default/files/4107/4107a3.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.